Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07465133

Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)

Conditions: Ovarian Cancer, Quality of Life

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 50
Sponsor: Helios University Hospital Wuppertal

Location: Helios University Clinic Wuppertal, University Witten/Herdecke Wuppertal North Rhine-Westphalia

Summary

The goal of this observational study is to pre-test the EORTC QLQ-OV39 to identify and resolve potential problems in its administration and to identify missing/redundant items. A preliminary evaluation of the measurement properties of the module will be carried out. The study includes patients with evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV) above the age of 18 years. The main aims are: 1. To conduct Phase 3a and 3b pre-testing of the preliminary EORTC-QLQ-OV39 Questionnaire to identify and resolve potential problems in its administration and to identify missing/redundant items according to the updated EORTC QLG Guidelines for Module Development, 5th Edition 2021.(16) 2. a preliminary assessment of the psychometric properties of the module Participants will \[describe the main tasks participants will be asked to, complete the OV39, C30 and debriefing interviews, as well as questions about their demographics and clinical data.

Eligibility Criteria

Inclusion Criteria: 1. Evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV) 2. Must be able and willing to complete the questionnaires. 3. Must be able to understand and speak the language in which the patient will complete the questionnaire. 4. Age \> 18 years Exclusion Criteria: * cognitive impairment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07465133). StuddyBuddy aggregates publicly available trial information.